30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Schwartz Jonathan David

Track

Insider profile

Performance

Overall performance
4.0
Performance over holding periods
4.0
30 days 90 days 120 days
Average return 11% 8.2% 15.1%
Success rate 74% 68% 82%
Transactions
11 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Schwartz Jonathan David's trades of Rocket Pharmaceuticals Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-02-13 2026-02-13
PrS Proposed sale
91,155
278.62
US$3,397,905 		91,155 278.62 US$3,397,905
2025-11-20 2025-11-18
S Sale
87,718 -14.5%
79.72
US$3,566,300 		87,718 -14.5% 79.72 US$3,566,300
2025-11-18 2025-11-18
PrS Proposed sale
62,918
82.22
US$2,027,194 		62,918 82.22 US$2,027,194
2025-08-20 2025-08-19
S Sale
805 -0.4%
3.00
US$2,412 		805 -0.4% 3.00 US$2,412
2025-08-19 2025-08-19
PrS Proposed sale
805
3.00
US$2,412 		805 3.00 US$2,412
2025-08-20 2025-08-18
S Sale
1,680 -0.7%
3.07
US$5,149 		1,680 -0.7% 3.07 US$5,149
2025-08-18 2025-08-18
PrS Proposed sale
1,680
3.07
US$5,150 		1,680 3.07 US$5,150
2025-08-18 2025-08-14
S Sale
11,161 -4.7%
3.02
US$33,695 		11,161 -4.7% 3.02 US$33,695
2025-08-14 2025-08-14
PrS Proposed sale
11,161
3.02
US$33,692 		11,161 3.02 US$33,692
2025-05-22 2025-05-20
S Sale
801 -0.3%
6.45
US$5,163 		801 -0.3% 6.45 US$5,163
2025-05-20 2025-05-20
PrS Proposed sale
801
6.45
US$5,163 		801 6.45 US$5,163
2025-05-20 2025-05-16
S Sale
1,582 -0.7%
6.53
US$10,327 		1,582 -0.7% 6.53 US$10,327
2025-05-16 2025-05-16
PrS Proposed sale
1,582
6.53
US$10,327 		1,582 6.53 US$10,327
2025-02-27 2025-02-25
S Sale
6,532 -2.7%
10.58
US$69,109 		6,532 -2.7% 10.58 US$69,109
2025-02-25 2025-02-25
PrS Proposed sale
6,532
10.58
US$69,117 		6,532 10.58 US$69,117
2025-02-27 2024-11-21
S Sale
3,097 -1.9%
13.05
US$40,416 		3,097 -1.9% 13.05 US$40,416
2025-02-27 2024-08-16
S Sale
2,710 -1.6%
18.50
US$50,135 		2,710 -1.6% 18.50 US$50,135
2025-02-27 2024-05-17
S Sale
2,754 -1.6%
23.35
US$64,306 		2,754 -1.6% 23.35 US$64,306
2023-05-17 2023-05-17
PrS Proposed sale
712
21.38
US$15,219 		712 21.38 US$15,219
2023-04-13 2023-04-13
PrS Proposed sale
10,880
17.66
US$192,141 		10,880 17.66 US$192,141
2023-04-11 2023-04-11
PrS Proposed sale
4,643
17.11
US$79,432 		4,643 17.11 US$79,432
2023-04-06 2023-04-06
PrS Proposed sale
12,390
16.98
US$210,404 		12,390 16.98 US$210,404
2023-02-22 2023-02-17
S Sale
3,557 -3.6%
19.06
US$67,796 		3,557 -3.6% 19.06 US$67,796
2022-04-01 2022-03-30
PlS Planned sale
34,438 -16.1%
16.56
US$570,293 		34,438 -16.1% 16.56 US$570,293
2022-04-01 2022-03-30
PlS Planned sale
10,562 -4.7%
15.94
US$168,358 		10,562 -4.7% 15.94 US$168,358